Alpha Teknova, Inc.

NasdaqGM TKNO

Alpha Teknova, Inc. Market Capitalization on January 14, 2025: USD 421.66 M

Alpha Teknova, Inc. Market Capitalization is USD 421.66 M on January 14, 2025, a 202.81% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Alpha Teknova, Inc. 52-week high Market Capitalization is USD 480.30 M on January 07, 2025, which is 13.91% above the current Market Capitalization.
  • Alpha Teknova, Inc. 52-week low Market Capitalization is USD 63.10 M on June 26, 2024, which is -85.03% below the current Market Capitalization.
  • Alpha Teknova, Inc. average Market Capitalization for the last 52 weeks is USD 212.90 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGM: TKNO

Alpha Teknova, Inc.

CEO Mr. Stephen Gunstream
IPO Date June 25, 2021
Location United States
Headquarters 2290 Bert Drive
Employees 210
Sector Health Care
Industries
Description

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

Similar companies

PROC

Procaps Group S.A.

USD 1.76

7.98%

LFCR

Lifecore Biomedical, Inc.

USD 6.43

1.10%

RGC

Regencell Bioscience Holdings Limited

USD 4.86

-4.71%

ANIP

ANI Pharmaceuticals, Inc.

USD 54.16

0.43%

PAHC

Phibro Animal Health Corporation

USD 20.28

0.05%

COLL

Collegium Pharmaceutical, Inc.

USD 33.18

-1.80%

ORGO

Organogenesis Holdings Inc.

USD 2.89

-3.67%

StockViz Staff

January 15, 2025

Any question? Send us an email